KRAS and neoplasm: The injections of ATO, VC or D-VC alone had only weak and partial tumor suppressing effects, but the ATO and D-VC combination had much more potent KRAS-mutant tumor suppressing impact compared to the group of tumor-bearing mice injected with ATO and VC [161].